Загрузка...
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...
Сохранить в:
| Опубликовано в: : | Res Sq |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Journal Experts
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7336712/ https://ncbi.nlm.nih.gov/pubmed/32702077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-25643/v1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|